Avascular Necrosis Trends and Forecast
The future of the global avascular necrosis market looks promising with opportunities in the hospital pharmacy, retail pharmacy, and online pharmacy markets. The global avascular necrosis market is expected to reach an estimated $853.8 million by 2030 with a CAGR of 5.8% from 2024 to 2030. The major drivers for this market are growing preference for less painful substitute bone grafting surgical procedures, rising preference for surgeries to treat osteonecrosis, and increasing adoption of nonsteroidal anti-inflammatory drugs.Avascular Necrosis by Segment
The study includes a forecast for the global avascular necrosis by type, treatment, diagnosis, end use, and region.Avascular Necrosis Market by Type [Shipment Analysis by Value from 2018 to 2030]:
- Trauma
- Non-Trauma
Avascular Necrosis Market by Treatment [Shipment Analysis by Value from 2018 to 2030]:
- Nonsteroidal Anti-Inflammatory Drugs (NSAIDS)
- Cholesterol Lowing Drugs
- Osteoporosis Drugs
- Blood Thinners
- Others
Avascular Necrosis Market by Diagnosis [Shipment Analysis by Value from 2018 to 2030]:
- Imaging
- Biopsy
- CT Scan
- PET
- X- Ray
Avascular Necrosis Market by End Use [Shipment Analysis by Value from 2018 to 2030]:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
Avascular Necrosis Market by Region [Shipment Analysis by Value from 2018 to 2030]:
- North America
- Europe
- Asia Pacific
- The Rest of the World
List of Avascular Necrosis Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies avascular necrosis companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the avascular necrosis companies profiled in this report include:- Novartis
- Pfizer
- Teva Pharmaceutical
- Mylan
- Zimmer Biomet
- Merck
- Enzo Biochem
- Atnahs
- Bone Therapeutics
- Vericel
Avascular Necrosis Market Insights
The publisher forecasts that non-trauma will remain the larger segment over the forecast period due to its rising usage among various treatments related to alcohol intake and abnormalities related to metabolism of bones.Within this market, hospital pharmacy is expected to witness the highest growth due to increasing number of hospitalized patients opting for non-invasive therapy and surgery to treat osteonecrosis.
North America will remain the largest region over the forecast period due to rising cases of avascular necrosis among individuals, increase in geriatric population, and presence of key players in the region.
Features of the Global Avascular Necrosis Market
- Market Size Estimates: Avascular necrosis market size estimation in terms of value ($M).- Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
- Segmentation Analysis: Avascular necrosis market size by various segments, such as by type, treatment, diagnosis, end use, and region in terms of value ($M).
- Regional Analysis: Avascular necrosis market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
- Growth Opportunities: Analysis of growth opportunities in different types, treatments, diagnosis, end uses, and regions for the avascular necrosis market.
- Strategic Analysis: This includes M&A, new product development, and competitive landscape of the avascular necrosis market.
- Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the avascular necrosis market size?Answer: The global avascular necrosis market is expected to reach an estimated $853.8 million by 2030.
Q2. What is the growth forecast for avascular necrosis market?
Answer: The global avascular necrosis market is expected to grow with a CAGR of 5.8% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the avascular necrosis market?
Answer: The major drivers for this market are growing preference for less painful substitute bone grafting surgical procedures, rising preference for surgeries to treat osteonecrosis, and increasing adoption of nonsteroidal anti-inflammatory drugs.
Q4. What are the major segments for avascular necrosis market?
Answer: The future of the avascular necrosis market looks promising with opportunities in the hospital pharmacy, retail pharmacy, and online pharmacy markets.
Q5. Who are the key avascular necrosis market companies?
Answer: Some of the key avascular necrosis companies are as follows:
- Novartis
- Pfizer
- Teva Pharmaceutical
- Mylan
- Zimmer Biomet
- Merck
- Enzo Biochem
- Atnahs
- Bone Therapeutics
- Vericel
Answer: The publisher forecasts that non-trauma will remain the larger segment over the forecast period due to its rising usage among various treatments related to alcohol intake and abnormalities related to metabolism of bones.
Q7. In avascular necrosis market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period due to rising cases of avascular necrosis among individuals, increase in geriatric population, and presence of key players in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, the publisher provides 10% customization without any additional cost.
This report answers the following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the avascular necrosis market by type (trauma and non-trauma), treatment (nonsteroidal anti-inflammatory drugs (NSAIDs), cholesterol lowing drugs, osteoporosis drugs, blood thinners, and others), diagnosis (imaging, biopsy, CT scan, PET, and x- ray), end use (hospital pharmacies, retail pharmacies, online pharmacies, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Global Avascular Necrosis Market : Market Dynamics
3. Market Trends and Forecast Analysis from 2018 to 2030
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
5. Competitor Analysis
6. Growth Opportunities and Strategic Analysis
7. Company Profiles of Leading Players
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Novartis
- Pfizer
- Teva Pharmaceutical
- Mylan
- Zimmer Biomet
- Merck
- Enzo Biochem
- Atnahs
- Bone Therapeutics
- Vericel
Methodology
The analyst has been in the business of market research and management consulting since 2000 and has published over 600 market intelligence reports in various markets/applications and served over 1,000 clients worldwide. Each study is a culmination of four months of full-time effort performed by the analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in the market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of professionals, who have analyzed and tracked the market over the years.
Extensive research and interviews are conducted in the supply chain of the market to estimate market share, market size, trends, drivers, challenges and forecasts.
Thus, the analyst compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. The analyst then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process.
LOADING...
